Hangzhou Dac Biotechnology Co., Ltd.

This is the first time researchers are testing the experimental drug DXC008 in people. The study aims to find the safest dose and check for early signs that it might help control advanced prostate cancer and other solid tumors like Ewing sarcoma. It will involve about 110 adults …